Pierre Péterlin

4.2k citations
110 papers · 1.2k · h-index 20

Impact in

  • Hematology top 1%
    • Hematopoietic Stem Cell Transplantation
    • Acute Myeloid Leukemia Research
  • Immunology top 10%
    • Immune Cell Function and Interaction
    • T-cell and B-cell Immunology

Papers in

  • Hematology 69
    • Hematopoietic Stem Cell Transplantation 40
    • Acute Myeloid Leukemia Research 34
    • Multiple Myeloma Research and Treatments 11
  • Immunology 28
    • Immune Cell Function and Interaction 14
Co-authors
Patrice Chevallier (83 shared papers)Thierry A. Guillaume (75 shared papers)Alice Garnier (63 shared papers)Philippe Moreau (49 shared papers)Amandine Lebourgeois (53 shared papers)Marie C. Béné (49 shared papers)Steven Le Gouill (34 shared papers)Mohamad Mohty (24 shared papers)
Journals
Blood (22 papers)Bone Marrow Transplantation (11 papers)Annals of Hematology (8 papers)Transplantation and Cellular Therapy (7 papers)Haematologica (6 papers)
Partner nations
FranceUnited StatesCanada

In The Last Decade

Pierre Péterlin

105 papers receiving 1.2k citations

Peers

Pierre Péterlin
Comparison fields: 5 of 70
  • Hematology 696
  • Immunology 319
  • Oncology 360
  • Genetics 125
  • Infectious Diseases 201
Replace Stéphanie Nguyen with:
Stéphanie Nguyen France
Federica Galaverna Italy
Xavier Poiré Belgium
Usama S. Gergis United States
Simona Lapusan France
Anna Ghiso Italy
Pascual Balsalobre Spain
Alice Garnier France
Sabine Fürst France
Andrew Grigg Australia
Pierre Péterlin relative to Stéphanie Nguyen France Stéphanie Nguyen's profile →
Citations per field
00.5×2×2.7×
Stéphanie Nguyen · 1×
Citations per year

Countries citing papers authored by Pierre Péterlin

Since Specialization
Citations

This map shows the geographic impact of Pierre Péterlin's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Pierre Péterlin with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Pierre Péterlin more than expected).

Fields of papers citing papers by Pierre Péterlin

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Pierre Péterlin. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Pierre Péterlin. The network helps show where Pierre Péterlin may publish in the future.

Co-authors

The 25 scholars most cited alongside Pierre Péterlin, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Pierre Péterlin Line = papers co-authored together Pierre Péterlin links everyone, so they are left out of the graph.

All Works

20 of 20 papers shown

Showing the 20 most-cited of 110 papers — load more, or switch the sort, to bring in the rest.

#Work
1
Prospective phase II study of prophylactic low-dose azacitidine and donor lymphocyte infusions following allogeneic hematopoietic stem cell transplantation for high-risk acute myeloid leukemia and myelodysplastic syndrome
Bone Marrow Transplantation ·Thierry A. Guillaume, Florent Malard, Léonardo Magro, Myriam Labopin, Reza Tabrizi, Cécile Borel, Patrice Chevallier, Stéphane Vigouroux, Pierre Péterlin, Alice Garnier, M. Thérèse Rubio, Anne Huynh, Noel Jean Milpied, Philippe Moreau, Béatrice Gaugler, Ibrahim Yakoub‐Agha, Mohamad Mohty
201964
2
Nationwide survey on the use of eltrombopag in patients with severe aplastic anemia: a report on behalf of the French Reference Center for Aplastic Anemia
Haematologica ·Étienne Lengliné, Bernard Drénou, Pierre Péterlin, Olivier Tournilhac, Julie Abraham, Ana Berceanu, Brigitte Dupriez, Gaëlle Guillerm, E. Raffoux, Flore Sicre de Fontbrune, Lionel Adès, Marie Balsat, Driss Chaoui, Paul Coppo, Sélim Corm, Thierry Leblanc, Natacha Maillard, Louis Terriou, Gèrard Socié, Régis Peffault de Latour
201750
3
Azacitidine salvage therapy for relapse of myeloid malignancies following allogeneic hematopoietic SCT
Bone Marrow Transplantation ·Benoît Tessoulin, Jean Delaunay, Patrice Chevallier, Marion Loirat, Sameh Ayari, Pierre Péterlin, Steven Le Gouill, Thomas Gastinne, Philippe Moreau, Mohamad Mohty, Thierry A. Guillaume
201449
4
Impact on early outcomes and immune reconstitution of high-dose post-transplant cyclophosphamide vs anti-thymocyte globulin after reduced intensity conditioning peripheral blood stem cell allogeneic transplantation
Oncotarget ·Christelle Retière, Catherine Willem, Thierry A. Guillaume, Henri Vié, Laetitia Gautreau‐Rolland, Emmanuel Scotet, Xavier Saulquin, Katia Gagne, Marie C. Béné, Berthe‐Marie Imbert, Béatrice Clemenceau, Pierre Péterlin, Alice Garnier, Patrice Chevallier
201849
5
Larger number of invariant natural killer T cells in PBSC allografts correlates with improved GVHD-free and progression-free survival
Blood ·Florent Malard, Myriam Labopin, Patrice Chevallier, Thierry A. Guillaume, Alix Duquesne, Fanny Rialland, Sophie Derenne, Pierre Péterlin, A.G. Chartois Leaute, Éolia Brissot, Marc Grégoire, Philippe Moreau, Philippe Saas, Béatrice Gaugler, Mohamad Mohty
201648
6
Safety and Antibody Response After 1 and 2 Doses of BNT162b2 mRNA Vaccine in Recipients of Allogeneic Hematopoietic Stem Cell Transplant
JAMA Network Open ·Amandine Lebourgeois, Marianne Coste‐Burel, Thierry A. Guillaume, Pierre Péterlin, Alice Garnier, Marie C. Béné, Patrice Chevallier
202145
7
Emergence and evolution of TP53 mutations are key features of disease progression in myelodysplastic patients with lower-risk del(5q) treated with lenalidomide
Haematologica ·Laurence Lodé, Audrey Ménard, Laurent Flet, Steven Richebourg, Marion Loirat, Marion Eveillard, Yannick Le Bris, Catherine Godon, Olivier Theisen, Anne-Laure Gagez, G. Cartron, Thérèse Commes, Bruno Villemagne, Odile Luycx, Pascal Godmer, Catherine Pellat‐Deceunynck, Thierry Soussi, Marie C. Béné, Jacques Delaunay, Pierre Péterlin
201739
8
Sequential regimen of clofarabine, cytosine arabinoside and reduced-intensity conditioned transplantation for primary refractory acute myeloid leukemia
Haematologica ·Mohamad Mohty, Florent Malard, Didier Blaise, Noel Jean Milpied, Gèrard Socié, Anne Huynh, Oumédaly Reman, Ibrahim Yakoub‐Agha, Sabine Fürst, Thierry A. Guillaume, Resa Tabrizi, Stéphane Vigouroux, Pierre Péterlin, Jean El Cheikh, Philippe Moreau, Myriam Labopin, Patrice Chevallier
201639
9
Progression of disease within 2 years (POD24) is a clinically relevant endpoint to identify high-risk follicular lymphoma patients in real life
Annals of Hematology ·Clara Sortais, Anne Lok, Benoît Tessoulin, Thomas Gastinne, Beatrice Mahé, Viviane Dubruille, Nicolas Blin, Cyrille Touzeau, (unknown), Céline J. Bossard, Pierre Péterlin, Alice Garnier, Thierry A. Guillaume, Amandine Lebourgeois, Patrice Chevallier, Philippe Moreau, Christophe Leux, Steven Le Gouill
202036
10
Prevalence of the reversed halo sign in neutropenic patients compared with non‐neutropenic patients: Data from a single‐centre study involving 27 patients with pulmonary mucormycosis (2003‐2016)
Mycoses ·Jessie Bourcier, Pierre‐Marie Heudes, Florent Morio, Thomas Gastinne, Patrice Chevallier, Fanny Rialland, Claire F. Garandeau, Isabelle Danner‐Boucher, Patrice Le Pape, Éric Frampas, Philippe Moreau, Claire Defrance, Pierre Péterlin
201734
11
Deconditioning, fatigue and impaired quality of life in long-term survivors after allogeneic hematopoietic stem cell transplantation
Bone Marrow Transplantation ·Stéphanie Dirou, Arnaud Chambellan, Patrice Chevallier, Patrick Germaud, Guillaume Lamirault, Pierre‐Antoine Gourraud, Bastien Perrot, Béatrice Delasalle, Bastien Forestier, Thierry A. Guillaume, Pierre Péterlin, Alice Garnier, A. Magnan, F.–X. Blanc, Patricia Lemarchand
201733
12
Impact of KIR/HLA Incompatibilities on NK Cell Reconstitution and Clinical Outcome after T Cell–Replete Haploidentical Hematopoietic Stem Cell Transplantation with Posttransplant Cyclophosphamide
The Journal of Immunology ·Catherine Willem, Dhon Roméo Makanga, Thierry A. Guillaume, Bercelin Maniangou, Nolwenn Legrand, Katia Gagne, Pierre Péterlin, Alice Garnier, Marie C. Béné, Anne Cesbron, Amandine Lebourgeois, Patrice Chevallier, Christelle Retière
201933
13
Upfront allogeneic stem-cell transplantation for patients with nonlocalized untreated peripheral T-cell lymphoma: an intention-to-treat analysis from a single center
Annals of Oncology ·Marion Loirat, Patrice Chevallier, Christophe Leux, Philippe Moreau, Céline J. Bossard, Thierry A. Guillaume, Thomas Gastinne, Jean Delaunay, Nicolas Blin, Beatrice Mahé, Viviane Dubruille, Karine Augeul-Meunier, Pierre Péterlin, Hervé Maisonneuve, Nadine Juge‐Morineau, Henry Jardel, Mohamad Mohty, Steven Le Gouill
201432
14
Prophylactic or Preemptive Low-Dose Azacitidine and Donor Lymphocyte Infusion to Prevent Disease Relapse following Allogeneic Transplantation in Patients with High-Risk Acute Myelogenous Leukemia or Myelodysplastic Syndrome
Transplantation and Cellular Therapy ·Thierry A. Guillaume, Sylvain Thépot, Pierre Péterlin, Patrice Céballos, Amandine Lebourgeois, Alice Garnier, Corentin Orvain, Aurélien Giltat, Sylvie François, Yannick Le Bris, Clémentine Fronteau, Lucie Planche, Patrice Chevallier
202129
15
Safety and immunogenicity of a first dose of SARS‐CoV‐2 mRNA vaccine in allogeneic hematopoietic stem‐cells recipients
eJHaem ·Patrice Chevallier, Marianne Coste‐Burel, Amandine Lebourgeois, Pierre Péterlin, Alice Garnier, Marie C. Béné, Berthe‐Marie Imbert, Thomas Drumel, Steven Le Gouill, Philippe Moreau, Beatrice Mahé, Viviane Dubruille, Nicolas Blin, Anne Lok, Cyrille Touzeau, Thomas Gastinne, Maxime Jullien, Sophie Vanthygem, Thierry A. Guillaume
202127
16
Single-agent daratumumab in very advanced relapsed and refractory multiple myeloma patients: a real-life single-center retrospective study
Annals of Hematology ·Maxime Jullien, Sabrina Trudel, Benoît Tessoulin, Beatrice Mahé, Viviane Dubruille, Nicolas Blin, Thomas Gastinne, Antoine Bonnet, Anne Lok, Amandine Lebourgeois, Pierre Péterlin, Alice Garnier, Patrice Chevalier, Thierry A. Guillaume, Patrick Thomaré, Steven Le Gouill, Philippe Moreau, Cyrille Touzeau
201924
17
SARS-CoV-2 T-Cell Responses in Allogeneic Hematopoietic Stem Cell Recipients following Two Doses of BNT162b2 mRNA Vaccine
Vaccines ·Béatrice Clemenceau, Thierry A. Guillaume, Marianne Coste‐Burel, Pierre Péterlin, Alice Garnier, Amandine Lebourgeois, Maxime Jullien, Jocelyn Ollier, Audrey Grain, Marie C. Béné, Henri Vié, Patrice Chevallier
202222
18
A phase I/II feasibility vaccine study by autologous leukemic apoptotic corpse-pulsed dendritic cells for elderly AML patients
Human Vaccines & Immunotherapeutics ·Patrice Chevallier, Soraya Saïagh, Virginie Dehame, Thierry A. Guillaume, Pierre Péterlin, Sylvain Bercegeay, Yannick Le Bris, Céline J. Bossard, Isabelle Gauvrit, Brigitte Dréno, Nadine Juge‐Morineau, Marie C. Béné, Marc Grégoire
202121
19
In-depth time-dependent analysis of the benefit of allo-HSCT for elderly patients with CR1 AML: a FILO study
Blood Advances ·Raynier Devillier, Édouard Forcade, Alice Garnier, Sarah Guenounou, Sylvain Thépot, Gaëlle Guillerm, Patrice Céballos, Yosr Hicheri, Pierre‐Yves Dumas, Pierre Péterlin, Mathilde Hunault, Marie C. Béné, Anne Bouvier, Patrice Chevallier, Didier Blaise, Norbert Vey, Arnaud Pigneux, Christian Récher, Anne Huynh
202120
20
Safety and antibody response after one and/or two doses of BNT162b2 Anti‐SARS‐CoV‐2 mRNA vaccine in patients treated by CAR T cells therapy
British Journal of Haematology ·Thomas Gastinne, Amandine Lebourgeois, Marianne Coste‐Burel, Thierry A. Guillaume, Pierre Péterlin, Alice Garnier, Berthe‐Marie Imbert, Thomas Drumel, Beatrice Mahé, Viviane Dubruille, Nicolas Blin, Anne Lok, Cyrille Touzeau, Benoît Tessoulin, Maxime Jullien, Sophie Vanthygem, Marie C. Béné, Philippe Moreau, Steven Le Gouill, Patrice Chevallier
202120

About Pierre Péterlin

Pierre Péterlin is a scholar working on Hematology, Immunology, Oncology, Genetics and Infectious Diseases, having authored 110 papers that have together received 1.2k indexed citations. Recurring topics across this work include Hematopoietic Stem Cell Transplantation (40 papers), Acute Myeloid Leukemia Research (34 papers), Immune Cell Function and Interaction (14 papers), Multiple Myeloma Research and Treatments (11 papers), SARS-CoV-2 and COVID-19 Research (11 papers), Acute Lymphoblastic Leukemia research (11 papers), Lymphoma Diagnosis and Treatment (9 papers) and Viral-associated cancers and disorders (8 papers). The work is most often cited by research in Hematology (696 citations), Immunology (319 citations), Oncology (360 citations), Genetics (125 citations) and Infectious Diseases (201 citations). Pierre Péterlin has collaborated with scholars based in France, United States and Canada. Frequent co-authors include Patrice Chevallier, Thierry A. Guillaume, Alice Garnier, Philippe Moreau, Amandine Lebourgeois, Marie C. Béné, Steven Le Gouill, Mohamad Mohty, Thomas Gastinne and Nicolas Blin. Their work appears in journals such as Blood, Bone Marrow Transplantation, Annals of Hematology, Transplantation and Cellular Therapy and Haematologica.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Stéphanie NguyenBreakdown of academic impact, for papers by Federica GalavernaBreakdown of academic impact, for papers by Xavier PoiréBreakdown of academic impact, for papers by Usama S. GergisBreakdown of academic impact, for papers by Simona LapusanBreakdown of academic impact, for papers by Anna GhisoBreakdown of academic impact, for papers by Pascual BalsalobreBreakdown of academic impact, for papers by Alice GarnierBreakdown of academic impact, for papers by Sabine FürstBreakdown of academic impact, for papers by Andrew Grigg